AntiTNF

PALO ALTO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that the Company and its regulatory…

A 1-year-old girl from Spain is the world's first successful recipient of a multi-visceral…

Physician’s Briefing Staff MONDAY, Sept. 26, 2022 (HealthDay News) -- For women with inflammatory bowel disease (IBD), continuation of anti-tumor…

Distinct blood protein profiles may help predict clinical relapse in Crohn's disease patients who…

NIH scientists discovered that enteric viruses such as norovirus and rotavirus can replicate and…

A new way of inhibiting tumor necrosis factor (TNF) for treating rheumatoid arthritis showed…

Tumor necrosis factor (TNF) inhibitor use early after a Crohn's disease diagnosis was associated…

Inflammatory bowel disease (IBD) patients on maintenance therapy with a tumor necrosis factor…